World Health Organization (WHO) risk level reductions in inpatients with alcohol use disorder and comorbid anxiety disorders.
Brittany L StevensonJustin AnkerPaul ThurasLinda RinehartMatt G KushnerPublished in: Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors (2022)
Though abstinence was associated with the best outcomes in this abstinence-based treatment sample, we conclude that reduced drinking is also associated with significant improvements in alcohol-related outcomes in inpatients with AUD and comorbid anxiety disorders.At 1-, 4-, and 12-months posttreatment, most patients reported abstinence (83, 63, and 60%), and 11, 25, and 26% reported drinking at a reduced level. Drinking reductions achieved at 1-month posttreatment were maintained at 12-month posttreatment by 74% of participants. Overall, the abstinent group reported the best psychological and functional outcomes at follow-ups, followed by the reduced group. Few differences were observed between reducers and nonreducers, but reducers reported significantly (PsycInfo Database Record (c) 2022 APA, all rights reserved).
Keyphrases
- alcohol use disorder
- alcohol consumption
- smoking cessation
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- peritoneal dialysis
- type diabetes
- emergency department
- physical activity
- adipose tissue
- metabolic syndrome
- depressive symptoms
- combination therapy
- glycemic control
- drug induced